QC
IMMX icon

Quent Capital’s Immix Biopharma IMMX Stock Holding History

Quent Capital’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+20,000
New +$186K 0.01% 413

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Quent Capital's IMMX Position: Q2 2026 in Review

Quent Capital opened a new position in Immix Biopharma (IMMX) in Q2 2026: 20,000 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #413 among its holdings.

109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Quent Capital held 20,000 shares of Immix Biopharma worth $206K as of Q2 2026.
  • Immix Biopharma was a new Quent Capital position in Q2 2026.
  • Immix Biopharma made up 0.01% of Quent Capital's portfolio in Q2 2026, its #413 holding.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.